Sunshine Biopharma Inc. (SBFM) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $12.26M | +14.9% |
| 2024 | $10.67M | +27.9% |
| 2023 | $8.34M | +391.5% |
| 2022 | $1.70M | +1434.0% |
| 2021 | $110.6K | +142.7% |
| 2020 | $45.6K | +352.4% |
| 2019 | $10.1K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $12.26M | +14.9% |
| 2024 | $10.67M | +27.9% |
| 2023 | $8.34M | +391.5% |
| 2022 | $1.70M | +1434.0% |
| 2021 | $110.6K | +142.7% |
| 2020 | $45.6K | +352.4% |
| 2019 | $10.1K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |